Exosomes News and Research

RSS
Stem cell breakthrough restores sight to sufferers of corneal disease

Stem cell breakthrough restores sight to sufferers of corneal disease

Zyflamend, herb-based therapeutic shows promise for high risk of prostate cancer

Zyflamend, herb-based therapeutic shows promise for high risk of prostate cancer

Protein synaptotagmin-IV helps maintain an efficient brain

Protein synaptotagmin-IV helps maintain an efficient brain

Automated tissue engineering on demand

Automated tissue engineering on demand

Cytomegalovirus may cause high blood pressure

Cytomegalovirus may cause high blood pressure

Non-wovens as scaffolds for artificial tissue

Non-wovens as scaffolds for artificial tissue

Fat capsules carry markers for deadly prostate cancer

Fat capsules carry markers for deadly prostate cancer

A more potent vaccine technology

A more potent vaccine technology

New early detection studies of lung cancer in non-smokers launched

New early detection studies of lung cancer in non-smokers launched

New hope for Huntington disease sufferers

New hope for Huntington disease sufferers

Scientists use RNA to reprogram 1 cell type into another

Scientists use RNA to reprogram 1 cell type into another

Slow-release anesthetic drug-delivery could change pain management

Slow-release anesthetic drug-delivery could change pain management

Single injection could treat pain days, weeks, maybe even months

Single injection could treat pain days, weeks, maybe even months

New understanding of roles of insulin in obesity or type II diabetes

New understanding of roles of insulin in obesity or type II diabetes

Mutations that help HIV hide undermine the virus's ability to replicate

Mutations that help HIV hide undermine the virus's ability to replicate

Natural heart pacemakers?

Natural heart pacemakers?

Researchers delve into blood cell generation process

Researchers delve into blood cell generation process

FDA approves IXIARO for Japanese encephalitis

FDA approves IXIARO for Japanese encephalitis

Nobilon's intranasal influenza vaccine begins phase I clinical development

Nobilon's intranasal influenza vaccine begins phase I clinical development

A natural immune response to HIV in exceptional patients

A natural immune response to HIV in exceptional patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.